Cumberland Pharmaceuticals Inc (CPIX)
1.51
+0.01
(+0.67%)
USD |
NASDAQ |
May 17, 16:00
1.58
+0.07
(+4.64%)
After-Hours: 20:00
Cumberland Pharmaceuticals Price to Book Value: 0.7795 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.7795 |
| May 16, 2024 | 0.7744 |
| May 15, 2024 | 0.7744 |
| May 14, 2024 | 0.8105 |
| May 13, 2024 | 0.8208 |
| May 10, 2024 | 0.795 |
| May 09, 2024 | 0.8983 |
| May 08, 2024 | 0.8621 |
| May 07, 2024 | 0.8157 |
| May 06, 2024 | 0.7899 |
| May 03, 2024 | 0.8139 |
| May 02, 2024 | 0.7778 |
| May 01, 2024 | 0.7315 |
| April 30, 2024 | 0.8242 |
| April 29, 2024 | 0.8731 |
| April 26, 2024 | 0.9066 |
| April 25, 2024 | 0.8757 |
| April 24, 2024 | 0.8293 |
| April 23, 2024 | 0.8448 |
| April 22, 2024 | 0.8345 |
| April 19, 2024 | 0.8242 |
| April 18, 2024 | 0.8499 |
| April 17, 2024 | 0.8087 |
| April 16, 2024 | 0.8036 |
| April 15, 2024 | 0.7984 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.8396 |
| April 11, 2024 | 0.8654 |
| April 10, 2024 | 0.8683 |
| April 09, 2024 | 0.8705 |
| April 08, 2024 | 0.9066 |
| April 05, 2024 | 0.9066 |
| April 04, 2024 | 0.9169 |
| April 03, 2024 | 0.886 |
| April 02, 2024 | 0.8911 |
| April 01, 2024 | 0.8654 |
| March 31, 2024 | |
| March 28, 2024 | 0.8045 |
| March 27, 2024 | 0.8572 |
| March 26, 2024 | 0.8189 |
| March 25, 2024 | 0.8189 |
| March 22, 2024 | 0.8668 |
| March 21, 2024 | 0.8668 |
| March 20, 2024 | 0.9003 |
| March 19, 2024 | 0.8764 |
| March 18, 2024 | 0.8955 |
| March 15, 2024 | 0.862 |
| March 14, 2024 | 0.862 |
| March 13, 2024 | 0.8668 |
| March 12, 2024 | 0.8716 |
| March 11, 2024 | 0.9697 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5515
Minimum
Jul 11 2023
2.195
Maximum
Dec 06 2021
1.025
Average
0.9568
Median
Oct 16 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.204 |
| Oragenics Inc | 6.627 |
Price to Book Value Related Metrics
| PS Ratio | 0.5551 |
| PEG Ratio | -0.0231 |
| Price to Free Cash Flow | 4.278 |
| Price | 1.51 |
| Earnings Yield | -39.07% |
| Market Cap | 21.43M |
| PEGY Ratio | -0.0231 |